Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00581672

Enrollment

224

Registered

2007-12-28

Start date

2010-07-25

Completion date

2022-05-03

Last updated

2022-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Anxiety, Black men, Prostate Cancer, 07-125

Brief summary

This study is being done to see if a standard tool used to check anxiety in white men works well for Black men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If the investigators have a good tool, it is more likely that the investigators can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).

Interventions

BEHAVIORALquestionnaires of quality of life

Subjects will be asked to complete the MAX-PC along with additional psychosocial questionnaires which include anxiety, depression coping methods, resilience spirituality, religiosity, and quality of life measures and will take approximately one 30 to 45 minutes to complete by patient.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years of age or older * Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results * Diagnosis of prostate cancer * Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic). * Ability to comprehend and complete questionnaires in English

Exclusion criteria

* Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol * Other non-Black or non-African-American ethnic groups

Design outcomes

Primary

Measure	Time frame
To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer.	within one to three weeks of receiving their PSA scores from their physician

Secondary

Measure	Time frame
To explore the prevalence of distress, anxiety, and depression in Black men with prostate cancer.	within one to three weeks of receiving their PSA scores from their physician

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026